Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg

NCT00650052 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Zonisamide Capsules 100 mg
DRUG: Zonegran® Capsules 100 mg

Sponsor

Mylan Pharmaceuticals Inc